Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

ARKRAY, Inc. engages in the manufacture and sale of medical and surgical equipment. It develops products that focus on diabetes testing and urinalysis. It also provides the medical testing systems and functional food materials. The company was founded by Tadashi Doi on June 10, 1960 and is headquartered in Kyoto, Japan.

Mitsui Chemicals, Inc. manufactures and sells petrochemicals and industrial inorganic chemical products. It operates through the following segments: Mobility, Healthcare, Food and Packaging, Base Material, and Others. The Mobility segment covers the new product development support business (solution business) for elastomers, functional compounds, functional polymers, polypropylene compounds, automobiles and other industrial products. The Healthcare segment includes vision care material, non-woven fabric, dental material, and personal care material. The Food and Packaging segment handles the coating and functional materials, functional films and sheets, and agricultural chemicals. The Base Material segment covers the ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, high-purity terephthalic acid, PET resins, polyurethane materials, and industrial chemicals. The Others segment comprises of other related businesses. The company was founded on July 1, 1955 and is headquartered in Tokyo, Japan.

Wistron Corporation, an original design manufacturer, provides a range of design, manufacturing, and after-sales service support functions for information and communication technology products worldwide. The company's product portfolio covers various technology products, including notebook personal computers (PCs), mobile communication products, servers and storage systems, networking products, desktop PCs, LCD TVs, information appliances, game consoles, and other consumer electronics. Its after-sales services include product replacement, repair and support, and product support solutions, both for products it manufactures and for products produced by other manufacturers. The company sells its products to various vendors who distribute these products under their own brands. Wistron Corporation was founded in 2001 and is headquartered in Taipei, Taiwan.

Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. The company passionately pursues its mission to improve the lives of all patients afflicted with cancer. Ventana Medical Systems discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the number one Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients. Ventana Medical Systems is a member of the Roche Group that is drawing on powerful partnerships with world-class scientific institutions.

Chengdu Hanchen Guangyi Biological Engineering Co., Ltd., established on 2019-07-19, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Production of Class II Medical Devices;medical service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Biochemical product technology research and development;Import and export;Technology Import and Export;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Financial Advisory;Sales of plastic products;software development;Information Technology Consulting Services;HR Services(Excludes job brokerage activities,Labor dispatch service);Instrument Manufacturing;Instrument sales;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Manufacturing of Power Electronic Components;Wholesale of electronic components;Electronic Components Retail;Sales of electronic components and electromechanical components;Sales of electronic special equipment;Electronic special equipment manufacturing;Research and development of bio-based material polymerization technology;electronic(gas)Manufacturing of physical equipment and other electronic equipment;electronic,Mechanical equipment maintenance(No special equipment);Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Engineering and Technology Research and Experimental Development;R&D of industrial enzyme preparations;Artificial intelligence public service platform technical consulting services;Machinery sales;Agricultural Machinery Sales;Refrigeration,Air Conditioning Equipment Sales;Industrial automatic control system device sales;Optical Instrument Sales;Office Equipment Sales;Office Supplies Sales;Sales of special instruments and meters for agriculture, forestry, animal husbandry and fishery;drawing,Manufacture of computing and measuring instruments;Sales of special equipment for agricultural and sideline food processing;Manufacturing of electronic components and electromechanical components.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Ningbo Love Gene Technology Co., Ltd., established on 2018-11-30, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Instrument Manufacturing;Manufacturing of experimental analysis instruments;Manufacturing of special instruments and meters for agriculture, forestry, animal husbandry and fishery;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Manufacturing of Drug Testing Instruments;sales agent;Specialty Chemicals Sales(Free of Hazardous Chemicals);Instrument sales;Agricultural Science Research and Experimental Development;Prevention and control of wild animal epidemics(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Veterinary drug production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Aridis Pharmaceuticals discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The company is utilizing its proprietary ʎPEXTM and MabIgX technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome infection and to rapidly manufacture monoclonal antibodies (mAbs) for the therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.

Shanghai Kuailing Biological Engineering Co., Ltd., established on 2017-11-07, Business scope includes licensed projects:Veterinary drug business;Import and export;Technology Import and Export;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in biotechnology,Internet information technology,computer technology,software technology,Technology development in the field of computer science and technology,technical consulting,technology transfer,Technical Services,Biological reagents for non-clinical diagnosis,laboratory equipment,Instrumentation,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals);Edible produce,Daily necessities,paper products,electronic product,Sales of Wujinjiaodian;business inquiries;account Serive,Sales of Class I Medical Devices,Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Kuailing Biotechnology Co., Ltd., established on 2006-06-02, Business scope includes practicing medicine,Research and development of diagnostic testing reagents for food safety and agriculture, animal husbandry and veterinary use,Packing and compounding,Sales;Biological experiment equipment,Medical equipment,Processing of R&D and production equipment for diagnostic testing reagents,Production,to assemble,Sales,Plastic packaging materials and plastic products(Non-leather,Styrofoam and other items involving toxic raw materials),Diagnostic test strip accessories(Fiber,Film Protective Film Strip,plastic sheet)processing and production,Sales,Engaged in the import and export of goods and technology,Own house rental. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Heimbiotek, Inc. is a private company headquartered in the South Korea. The firm develops gene detection, analysis and diagnosis technology.

At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems. A royal commission, entitled The Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis, was set up in 1901. It aimed to find out whether tuberculosis in animals and humans was the same disease and whether animals and humans could infect each other. This page describes how, by 1919, the Commission had evolved into the independent Medical Research Council.

Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. Its products include toripalimab injection, UBP1211, JS002, and UBP1213. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China.

Jiaxing Yakangbo Medical Laboratory Co., Ltd., established on 2011-09-02, The scope of business includes medical laboratory(clinical body fluid,blood specialty,clinical microbiology major,clinical chemistry laboratory,clinical immunization,Serology major,Clinical Cytomolecular Genetics Major);Pathology;medical instruments(one type,Class II,Three categories)research and development,wholesale,retail;Biotechnology,Technology development of medical diagnostic technology,Technical Services,technical consulting,technology transfer;Non-Certificate Vocational Skills Training for Adults;Genetic Testing Services;Genetic testing information consultation;Medical institution management consulting;Medical institution management;engaged in import and export business;Technology development of computer software,Technical Services;computer system integration,maintain.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Develops pharmaceutical products for serious viral diseases and cancer

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners.

Oxford University (Suzhou) Technology Co., Ltd., established on 2017-08-21, Business scope includes licensed projects:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Artificial intelligence industry application system integration service;Engineering and Technology Research and Experimental Development;Research and development of special electronic materials;Natural science research and experimental development;Conference and Exhibition Services;Entrepreneurial Space Services;For-profit private training institutions engaged in scientific and technological training(In addition to the subject classes for primary and middle school students,Language and cultural education and training);Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

HYK Gene is the research and development of gene sequencing platforms .They are applications of gene sequencing technology in pharmaceutical research and development, medical services, agriculture, general health, data, and other fields.